Screener
Immunome IMNM Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Immunome’s reported figures.
The source filing: Immunome’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
FAQ
- What is Immunome's invested capital?
- Immunome (IMNM) reported invested capital of $9.69M in Q1 2026.
- How has Immunome's invested capital changed year-over-year?
- Immunome's invested capital decreased by 82.2% year-over-year, from $54.28M to $9.69M.
- What is the long-term trend for Immunome's invested capital?
- Over 4 years (2020 to 2025), Immunome's invested capital has grown at a 64.7% compound annual growth rate (CAGR), from $2.08M to -$15.28M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Immunome's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude